Digital Monitoring of Self-reported Symptoms by Patients Treated With Cabozantinib Plus Nivolumab for Advanced Clear-cell Renal Carcinoma

Clinical trial NCT07028125 · RECRUITING

Trial details

NCT number: NCT07028125
Sponsor: Centre Francois Baclesse
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Renal Cell Carcinoma (Kidney Cancer)Metastatic Renal Cell Carcinoma Locally Advanced

Start date: 2025-10-01
Primary completion: 2028-10-01
Enrollment: 83

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.